Total Payments
$48,108
2024 Payments
$9,504
Companies
66
Transactions
676
Medicare Patients
2,309
Medicare Billing
$91,046
Payment Breakdown by Category
Food & Beverage$20,697 (43.0%)
Consulting$9,925 (20.6%)
Travel$9,009 (18.7%)
Other$8,300 (17.3%)
Education$175.93 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,697 | 632 | 43.0% |
| Consulting Fee | $9,925 | 5 | 20.6% |
| Travel and Lodging | $9,009 | 20 | 18.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,300 | 7 | 17.3% |
| Education | $175.93 | 12 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Inari Medical, Inc. | $27,295 | 60 | $0 (2024) |
| Abbott Laboratories | $2,833 | 38 | $0 (2024) |
| Penumbra, Inc. | $2,547 | 14 | $0 (2024) |
| ABIOMED | $2,097 | 29 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,774 | 94 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,003 | 39 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $925.97 | 34 | $0 (2024) |
| Medtronic, Inc. | $889.15 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $839.94 | 22 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $800.81 | 40 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,504 | 78 | Inari Medical, Inc. ($7,675) |
| 2023 | $9,525 | 89 | Inari Medical, Inc. ($6,949) |
| 2022 | $14,636 | 104 | Inari Medical, Inc. ($11,918) |
| 2021 | $3,217 | 88 | Inari Medical, Inc. ($753.70) |
| 2020 | $1,909 | 56 | Medtronic Vascular, Inc. ($217.98) |
| 2019 | $4,012 | 83 | Penumbra, Inc. ($1,839) |
| 2018 | $2,690 | 81 | ABIOMED ($1,316) |
| 2017 | $2,616 | 97 | Penumbra, Inc. ($471.99) |
All Payment Transactions
676 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $29.53 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/17/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $140.32 | General |
| Category: VTE | ||||||
| 12/13/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/12/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $27.58 | General |
| Category: Peripheral Intervention | ||||||
| 12/06/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $29.60 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/05/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: Genetic Disease | ||||||
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $32.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/24/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.57 | General |
| 11/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $31.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $50.87 | General |
| Category: Transcatheter Valve Systems | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $32.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $24.33 | General |
| 10/09/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $68.10 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $33.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/24/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Genetic Disease | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $25.62 | General |
| 09/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $33.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Not Applicable | ||||||
| 09/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 699 | 988 | $56,672 | $18,561 |
| 2022 | 7 | 446 | 632 | $42,039 | $14,784 |
| 2021 | 10 | 741 | 1,021 | $87,258 | $27,929 |
| 2020 | 10 | 423 | 512 | $93,380 | $29,772 |
Total Patients
2,309
Total Services
3,153
Medicare Billing
$91,046
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 63 | $17,881 | $6,704 | 37.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 507 | 729 | $17,081 | $5,139 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 32 | $6,203 | $2,055 | 33.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 34 | 35 | $6,710 | $2,035 | 30.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $4,236 | $1,315 | 31.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 47 | 88 | $3,858 | $1,108 | 28.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 29 | 30 | $702.15 | $204.68 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 79 | $15,739 | $6,348 | 40.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 274 | 381 | $9,174 | $2,875 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 14 | $4,040 | $1,451 | 35.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 13 | 14 | $4,275 | $1,369 | 32.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 19 | 19 | $3,778 | $1,212 | 32.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 45 | 85 | $3,774 | $1,127 | 29.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2022 | 17 | 18 | $728.10 | $233.73 | 32.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 21 | 22 | $529.76 | $169.20 | 31.9% |
| 93458 | Insertion of catheter in left heart for imaging of blood vessels and left lower heart including imaging interpretation and supervision and injection | Facility | 2021 | 28 | 28 | $26,935 | $7,622 | 28.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 99 | $19,743 | $7,301 | 37.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 450 | 610 | $14,827 | $4,497 | 30.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 26 | $7,688 | $3,154 | 41.0% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 30 | 30 | $6,014 | $1,753 | 29.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 68 | 131 | $6,023 | $1,712 | 28.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 13 | $2,746 | $854.88 | 31.1% |
| 99152 | Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | Facility | 2021 | 40 | 42 | $1,559 | $504.84 | 32.4% |
| 76937 | Ultrasound guidance for accessing into blood vessel | Facility | 2021 | 17 | 22 | $893.86 | $276.32 | 30.9% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 20 | 20 | $829.60 | $255.17 | 30.8% |
About Dr. Hal Chadow, M.D
Dr. Hal Chadow, M.D is a Cardiovascular Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1669466835.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hal Chadow, M.D has received a total of $48,108 in payments from pharmaceutical and medical device companies, with $9,504 received in 2024. These payments were reported across 676 transactions from 66 companies. The most common payment nature is "Food and Beverage" ($20,697).
As a Medicare-enrolled provider, Chadow has provided services to 2,309 Medicare beneficiaries, totaling 3,153 services with total Medicare billing of $91,046. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Brooklyn, NY
- Active Since 09/02/2005
- Last Updated 05/18/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1669466835
Products in Payments
- CT THROMBECTOMY SYSTEM KIT (Device) $18,009
- FLOWTRIEVER CATHETER, S (Device) $9,286
- Indigo (Device) $2,476
- Impella (Device) $2,097
- ENTRESTO (Drug) $1,707
- XARELTO (Drug) $941.23
- LifeVest (Device) $925.97
- DRAGONFLY OPSTAR (Device) $902.27
- ELIQUIS (Drug) $791.08
- Dragonfly OCT (Device) $721.62
- Resolute (Device) $566.59
- UPTRAVI (Drug) $542.07
- VERQUVO (Drug) $414.96
- OPSUMIT (Drug) $349.94
- OFEV (Drug) $311.80
- JARDIANCE (Drug) $280.89
- BRILINTA (Drug) $267.30
- SYMPLICITY G3 (Device) $260.00
- LOKELMA (Drug) $236.88
- Barostim Neo System (Device) $223.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brooklyn
Dr. Felix Yang, M.d, M.D
Cardiovascular Disease — Payments: $599,451
Cardiovascular Disease $599,451
Ozgen Dogan, Md, MD
Cardiovascular Disease — Payments: $367,116
Cardiovascular Disease $367,116
Dr. Adam Budzikowski, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $346,063
Cardiovascular Disease $346,063
Dr. Peter Rouvelas, M.d, M.D
Cardiovascular Disease — Payments: $339,378
Cardiovascular Disease $339,378
Dr. Ronald Wharton, M.d, M.D
Cardiovascular Disease — Payments: $298,083
Cardiovascular Disease $298,083
Dr. Sorin Brener, Md, MD
Cardiovascular Disease — Payments: $225,799
Cardiovascular Disease $225,799